Literature DB >> 20824182

Point of View: In the eye of the beholder: Preferences of patients, family physicians, and surgeons for lumbar spinal surgery.

Steven J Atlas1.   

Abstract

Entities:  

Year:  2010        PMID： 20824182      PMCID： PMC2931591          DOI： 10.1097/BRS.0b013e3181b666f8

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN： 0362-2436            Impact factor:   3.468


× No keyword cloud information.
  6 in total

Review 1.  What rate of utilization is appropriate in musculoskeletal care?

Authors:  Jon D Lurie; John Erik Bell; Jim Weinstein
Journal:  Clin Orthop Relat Res       Date:  2009-05-19       Impact factor: 4.176

2.  Hospital readmission rates for cohorts of Medicare beneficiaries in Boston and New Haven.

Authors:  E S Fisher; J E Wennberg; T A Stukel; S M Sharp
Journal:  N Engl J Med       Date:  1994-10-13       Impact factor: 91.245

3.  Informed patient choice: patient-centered valuing of surgical risks and benefits.

Authors:  James N Weinstein; Kate Clay; Tamara S Morgan
Journal:  Health Aff (Millwood)       Date:  2007 May-Jun       Impact factor: 6.301

4.  Rapid magnetic resonance imaging vs radiographs for patients with low back pain: a randomized controlled trial.

Authors:  Jeffrey G Jarvik; William Hollingworth; Brook Martin; Scott S Emerson; Darryl T Gray; Steven Overman; David Robinson; Thomas Staiger; Frank Wessbecher; Sean D Sullivan; William Kreuter; Richard A Deyo
Journal:  JAMA       Date:  2003-06-04       Impact factor: 56.272

Review 5.  Modifying unwarranted variations in health care: shared decision making using patient decision aids.

Authors:  Annette M O'Connor; Hilary A Llewellyn-Thomas; Ann Barry Flood
Journal:  Health Aff (Millwood)       Date:  2004       Impact factor: 6.301

6.  BRIEF REPORT: Patient-physician agreement as a predictor of outcomes in patients with back pain.

Authors:  Thomas O Staiger; Jeffrey G Jarvik; Richard A Deyo; Brook Martin; Clarence H Braddock
Journal:  J Gen Intern Med       Date:  2005-10       Impact factor: 5.128
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.